AbbVie
ABBV
ABBV
3,298 hedge funds and large institutions have $198B invested in AbbVie in 2023 Q4 according to their latest regulatory filings, with 359 funds opening new positions, 1,166 increasing their positions, 1,415 reducing their positions, and 98 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3,298
Holders Change
+207
Holders Change %
+6.7%
% of All Funds
48.34%
Holding in Top 10
200
Holding in Top 10 Change
-22
Holding in Top 10 Change %
-9.91%
% of All Funds
2.93%
New
359
Increased
1,166
Reduced
1,415
Closed
98
Calls
$4.51B
Puts
$2.44B
Net Calls
+$2.07B
Net Calls Change
+$494M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$5.57B |
| 2 |
BlackRock
New York
|
+$801M |
| 3 |
Capital International Investors
Los Angeles,
California
|
+$394M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$370M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$367M |
